As of 2026-03-13, the Relative Valuation of Vaxart Inc (VXRT) is (2.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 USD, the upside of Vaxart Inc based on Relative Valuation is -956.0%.
The range of the Relative Valuation is (2.43) - (2.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 23.9x | 21.2x |
| Forward P/E multiples | 18.1x - 22.5x | 21.6x |
| Fair Price | (2.43) - (2.88) | (2.74) |
| Upside | -859.2% - -1000.0% | -956.0% |
| Date | P/E |
| 2026-03-12 | -5.76 |
| 2026-03-11 | -6.00 |
| 2026-03-10 | -6.02 |
| 2026-03-09 | -6.25 |
| 2026-03-06 | -5.77 |
| 2026-03-05 | -5.63 |
| 2026-03-04 | -5.94 |
| 2026-03-03 | -5.86 |
| 2026-03-02 | -6.07 |
| 2026-02-27 | -6.21 |
| 2026-02-26 | -5.87 |
| 2026-02-25 | -5.62 |
| 2026-02-24 | -5.70 |
| 2026-02-23 | -4.98 |
| 2026-02-20 | -4.61 |
| 2026-02-19 | -4.35 |
| 2026-02-18 | -4.27 |
| 2026-02-17 | -4.35 |
| 2026-02-13 | -4.42 |
| 2026-02-12 | -4.41 |
| 2026-02-11 | -4.49 |
| 2026-02-10 | -4.61 |
| 2026-02-09 | -4.73 |
| 2026-02-06 | -4.74 |
| 2026-02-05 | -4.87 |
| 2026-02-04 | -4.91 |
| 2026-02-03 | -5.03 |
| 2026-02-02 | -4.75 |
| 2026-01-30 | -4.53 |
| 2026-01-29 | -4.76 |
| 2026-01-28 | -5.00 |
| 2026-01-27 | -5.06 |
| 2026-01-26 | -5.12 |
| 2026-01-23 | -5.23 |
| 2026-01-22 | -5.16 |
| 2026-01-21 | -5.16 |
| 2026-01-20 | -5.38 |
| 2026-01-16 | -5.48 |
| 2026-01-15 | -5.08 |
| 2026-01-14 | -4.29 |
| 2026-01-13 | -4.14 |
| 2026-01-12 | -6.25 |
| 2026-01-09 | -5.31 |
| 2026-01-08 | -3.75 |
| 2026-01-07 | -3.26 |
| 2026-01-06 | -3.04 |
| 2026-01-05 | -2.98 |
| 2026-01-02 | -2.85 |
| 2025-12-31 | -2.71 |
| 2025-12-30 | -2.74 |